Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myelogenous Leukemia, BCR/ABL Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT02890758
What this trial is testing

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+11 more
Brenda Cooper, MD 14
Early research (Phase 1)Study completedNCT01164163
What this trial is testing

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more
Children's Oncology Group 49
Not applicableNot Yet RecruitingNCT07413263
What this trial is testing

Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myeloid Leukemia
Assiut University 75
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Early research (Phase 1)Ended earlyNCT00464113
What this trial is testing

Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Exelixis 49
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Large-scale testing (Phase 3)Ended earlyNCT00038805
What this trial is testing

Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01003054
What this trial is testing

Autologous Transplantation for Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01294618
What this trial is testing

Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hospices Civils de Lyon 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03622788
What this trial is testing

Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+10 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00750659
What this trial is testing

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation
Sheba Medical Center 24
Not applicableEnded earlyNCT02145039
What this trial is testing

Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

Who this might be right for
Acute LeukemiasBurkitt's LymphomaChronic Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 2
Large-scale testing (Phase 3)Study completedNCT02130557
What this trial is testing

Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
Pfizer 536
Early research (Phase 1)Study completedNCT01110473
What this trial is testing

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaB-cell Chronic Lymphocytic Leukemia+2 more
AbbVie (prior sponsor, Abbott) 52
Testing effectiveness (Phase 2)Study completedNCT00795769
What this trial is testing

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more
Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00067002
What this trial is testing

Randomized Double Cord Blood Transplant Study

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Myelocytic, AcuteLeukemia, Myeloid, Chronic+1 more
M.D. Anderson Cancer Center 110
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Early research (Phase 1)Ended earlyNCT00101231
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 88
Not applicableUnknownNCT05080829
What this trial is testing

Myeloid Mutations Register in R/R CML

Who this might be right for
Chronic Myeloid Leukaemia RecurrentChronic Myeloid Leukemia, in Relapse
Grupo Cooperativo de Hemopatías Malignas 29
Next Page